Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by KelownaClownon Dec 01, 2021 10:40am
70 Views
Post# 34184807

RE:Facility buildout completed

RE:Facility buildout completed
Petespipe wrote: Looking like THC Biomed is all profits from here on. If they phase out selling dried product and just sell 100% edibles this company will succeed. It's been proven by the bigger companies that have not shown any profits while downsizing and still failing as cannabis prices keep dropping. THC Biomed is one of the only producers able to make full spectrum edibles at the lowest cost resulting in lower prices. Next Quarter will grow substantially in net profit. Growing pains are in the past, good luck

Dude, you are absolutely dreaming. You've cherry-picked a couple of comments and ignored the really important stuff. Look at the mortgages they have to pay monthly, the re-negotiated loans.

How about this statement: The Company’s expected source of cash flow in the upcoming year will be through sales and debt or equity
financing. Cash on hand at October 31, 2021 and expected cash flows for the next 12 months are not sufficient
to fund the Company’s ongoing operational and expansion needs. The Company will need funding through
equity or debt financing, entering into joint venture agreements, or a combination thereof.

Or this statement: LIQUIDITY
The Company does not have positive cash flow from operations; accordingly, it must rely on equity financing
and debt to fund operations.

The Company’s current liabilities total $5,035,152 (July 31, 2021 - $5,968,492) is comprised of accounts
payable and accrued liabilities of $2,700,184 (July 31, 2021 - $3,041,464); commercial operating loan of
$471,820 (July 31, 2021 - $486,004); current portion of the mortgages payable of $1,036,217 (July 31, 2021 -
$1,482,368); current portion of other liabilities being the right-of-use leases of $150,835 (July 31, 2021 -
$167,104); and convertible debentures payable of $676,096 (July 31, 2021 - $791,552).

As of the date of this MD&A, the Company has insufficient working capital to meet its ongoing financial
obligations for the coming year.


<< Previous
Bullboard Posts
Next >>